Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/detail.php on line 234

Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 82

Warning: array_push() expects parameter 1 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 85
Pharmalicensing | Life Science's Global Technology Marketplace
Save this technology
close
Save to Existing Project
Save to a New Project
Rapid Detection of Urinary Tract Infection
Yeda R&D Co. Ltd Israel flag Israel
Abstract ID:
A novel diagnostic technology for urinary tract infection. Infectious diseases remain one of the greatest challenges to global health. Urinary tract infection (UTI) is considered to be the most common bacterial infection and poses a significant......
Contact Tal Shapira, m.sc.
Participants
You
Email me a copy of this message

A novel diagnostic technology for urinary tract infection. Infectious diseases remain one of the greatest challenges to global health. Urinary tract infection (UTI) is considered to be the most common bacterial infection and poses a significant healthcare burden. Almost 50% of the global population will suffer from a UTI at some point in their lives. Financially, the estimated global annual cost of UTI is significant, at approximately $5 billion. A key barrier towards improving the management of UTI is the absence of rapid and accurate diagnostic information to direct treatment decisions. The current technologies employed for UTI diagnostics are slow, expensive and prone to human errors. The outlined technology is a simple, rapid, inexpensive, semi-automated and accurate UTI diagnostic test.


Applications






    • The technology represents a rapid, reliable and high-throughput UTI diagnostics platform.





    • The technology can potentially be harnessed to diagnose other forms of bacterial infection.





Advantages






    • Positive/negative results after few hours, as compared to 2-3 days in gold standard methods.





    • Precise, computer-managed, one step protocol (free of human error).





    • No sample processing or pre-incubation required





    • High throughput.





    • Low cost.





Technology's Essence


The technology employs real-time monitoring and computational analysis of non-isolative liquid urine cultures using existing off-the-shelf technology. It allows for rapid determination of Colony Forming Unit (CFU) value without the need to perform manual colony counting.


Licensing Status

GO PREMIUM TO GET PATENT INFORMATION
FEATURED
Last Updated May 2016
Technology Type DIAGNOSTIC
Phase of Development EARLY STAGE
CORPORATION